chrisvoncsefalvay/vaers-outcomes huggingface dataset:
it was an absolute nightmare,Severe side effects,the booster was worst than second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (it was an absolute nightmare,Severe side effects,the booster was worst than second vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (it was an absolute nightmare,Severe side effects,the booster was worst than second vaccine). At the time of the report, VACCINATION COMPLICATION (it was an absolute nightmare,Severe side effects,the booster was worst than second vaccine) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Dec-2021: Followup received contains No new information.
Nightmares; Noted cognition impact; Difficulty staying asleep (2am, 4am wakeups with insomnia) then difficulty fully waking in the morning; New general tiredness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 11:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included wolff-parkinson-white syndrome (oblated in 1999), sleep apnea (CPAP), obesity, blood pressure high (treated), bipolar disorder (treated) and gout from an unknown date. The patient was allergic to garlic (vegetable allergy). Concomitant medications included venlafaxine hydrochloride extended release (MANUFACTURER UNKNOWN) 37.5mg, losartan (MANUFACTURER UNKNOWN) 50mg and ULORIC from an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced nightmares (M.Night shamadome had nothing on her, the patient was dreaming complete "movies" including plot twists), new general tiredness, difficulty staying asleep (2am, 4am wakeups with insomnia) then difficulty fully waking in the morning, cognition impact, may be direct results of 2 above. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events nightmares, new general tiredness, difficulty staying asleep (2am, 4am wakeups with insomnia) then difficulty fully waking in the morning and cognition impact was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
The injection site is still swollen, very sore and bright red, 2 days after the injection.  It seems a long time.
Chills and fever 12 hours after injection.; Chills and fever 12 hours after injection.; Lingering body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er2613), via an unspecified route of administration in the left arm on an unspecified date in Mar2021 at 10:30 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes. Concomitant medication included metformin (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6201) via an unspecified route of administration in the left arm on an unspecified date in Feb2021 at 10.30 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in Mar2021 at 23:30, the patient experienced chills and fever twelve hours after injection and later it subsided after twelve hours. The patient also had lingering body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events chills, fever and lingering body aches was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
LOCALISED PAIN, INFLAMMATION, SWELLING, STARTED BY THE SECOND DAY REPORTED 5 DAYS AFTER VACCINE. HOWEVER, ON THE 5 TH DAY SWELLING WAS REDUCING. PT WAS RECOMMENDED TO USE COLD COMPRESS AS TOLERATED, AND TO FOLLOW UP WITH PRIMARY CARE IF SWELLING DOESN'T REDUCE OR INCREASE. ANY TIME IF THERE IS DIZZINESS  THEN GET PROMPT MEDICAL ATTENTION. PT HAS ALREADY TRAVELED TO ANOTHER STATE AND BACK.
Patient reports that immediately after receiving her Pfizer booster shot, she felt a sharp pain that radiated from her underarm to her breast. Reports that lymph nodes on same side of neck and area under her arm became swollen. Reports that symptoms lasted for 4 days but did not prohibit her from working. Denies fever.
Headache, Myalgia, Arthralgia,  chills, heavy perspiration Narrative:
This case was reported by a nurse and described the occurrence of expired vaccine used in a patient who received FLUARIX (batch number FS575, expiry date 30th June 2014). On 23rd October 2014, the patient received FLUARIX .5 ml. On an unknown date, an unknown time after receiving FLUARIX, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional information received: 18 pts were involved and investigation still ongoing. Caller did not have pt info. Maladministration caught on 10/23/14.
Needed help getting in bathtub; Legs pain; Neck pain; Jaw pain; Ear pain; Excruciating lower back pain; Severe headache; Stomach was on fire; Sore arm; Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach was on fire), GAIT DISTURBANCE (Needed help getting in bathtub), PAIN IN EXTREMITY (Legs pain), NECK PAIN (Neck pain) and PAIN IN JAW (Jaw pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for an unknown indication.    No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) at an unspecified dose. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and TENDERNESS (Tenderness). On 07-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach was on fire), PAIN IN EXTREMITY (Legs pain), NECK PAIN (Neck pain), PAIN IN JAW (Jaw pain), EAR PAIN (Ear pain), BACK PAIN (Excruciating lower back pain) and HEADACHE (Severe headache). On 08-Apr-2021, the patient experienced GAIT DISTURBANCE (Needed help getting in bathtub). At the time of the report, ABDOMINAL PAIN UPPER (Stomach was on fire), PAIN IN EXTREMITY (Legs pain), NECK PAIN (Neck pain), PAIN IN JAW (Jaw pain), EAR PAIN (Ear pain), PAIN IN EXTREMITY (Sore arm), TENDERNESS (Tenderness), BACK PAIN (Excruciating lower back pain) and HEADACHE (Severe headache) outcome was unknown and GAIT DISTURBANCE (Needed help getting in bathtub) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient have treatment like pain ointment.
Loss of taste smell hearing and blurred vision about 10% after second injection. Increase in Psoriasis all over my entire body! Gout !Everywhere. I felt horrible for three weeks, no energy unable to eat or sleep. My bones still ache in May 2021. I did not tell anyone for fear they would not get vaccinated.
OBSTRUCTIVE SLEEP APNEA 10/28/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
6 days post vaccine, child presented to office with seizure activity. The medical record states febrile seizure and MMR reaction.
1st shot: Sore arm for 5 days and discoloration in skin at the injection area 2nd shot: Within 12 hours experienced chills, muscle aches and pains, restless legs, stiffness in joint, sore arm, headaches, nausea, loss of appetite, abdominal discomfort. Lasted for 2 days
This spontaneous report as received from a pharmacist refers to a 63 year old patient. On 26-JUL-2017, the patient was vaccinated with ZOSTAVAX lot # M039452 for prophylaxis. Concomitant therapies included sterile diluent (STERILE DILUENT). On 26-JUL-2017, 1 day after onset of therapy the patient experienced incorrect product storage. On an unknown date, the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to ZOSTAVAX.    Additional information is not expected.; Sender's Comments: US-009507513-1708USA012397: US-009507513-1708USA012398: US-009507513-1708USA012396: US-009507513-1708USA012399: US-009507513-1707USA007162: US-009507513-1708USA012395:
Sore Arm; Corn Size Bruise; Bleeding Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Corn Size Bruise), VACCINATION SITE HAEMORRHAGE (Bleeding Injection Site) and PAIN IN EXTREMITY (Sore Arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced CONTUSION (Corn Size Bruise) and VACCINATION SITE HAEMORRHAGE (Bleeding Injection Site). On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 21-Mar-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. At the time of the report, CONTUSION (Corn Size Bruise) had not resolved and VACCINATION SITE HAEMORRHAGE (Bleeding Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
"Patient called in reporting she received both flu and pnemonia vaccines in the bicep area of her arm. She states her B/P went up very high and had a fever. Went to urgent care for treatment. Doctor questioned site of injection. Started on z-pack and steroids; doctor stated she has cellulitis."
administered expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. It was reported that the vial did not undergo temperature excursion and it was unknown when the vial was initially stored in the refrigerator. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contains Non significant information.
On 2/14/18 Received Tdap and MENACTRA in left deltoid after discussing with guardian and informed of no history of previous reactions to vaccines. 2/15/18 school Nurse called and said had small area of redness and swelling - F/U calls 2/16 and 2/20. 2/20/18 (L) arm swelling and redness resolved and now normal.
This case was reported by a pharmacist and described the occurrence of numbness at the injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of FLUARIX (unknown). At an unspecified time after vaccination with FLUARIX, the subject experienced numbness at the injection site and injection site tingling. At the time of reporting the outcome of the events were unspecified. The pharmacist reported during a FLUARIX administration, there were two complaints of numbness and tingling at the injection site. For the other case please see A0999335A.
Patient noted left arm red, hot, painful at site of injection which lasted until 11/26/2010; called PMD; instructed to take Tylenol q6h; relief noted.
On June 8, 2017 patient received her ADACEL and MENACTRA shots. She had been a healthy girl only missing 2 days of school that year. 48 hours after the shots she developed a fever (101) with sore throat and upper respiratory cold. The fever, sore throat, and cold resolved in about a week, but she still reported "not feeling well". She describes it as the feeling right before you get sick - you feel a little sick and know you aren't 100% well. She describes it as feeling 85%. She has muscle aches and twitching. She has had these symptoms for 5 months, and it all started 48 hours after the shots. We have visited out primary care physician. She ordered the attached labs, but all came back normal. After 5 months, we visited our neurologist, but only supplement recommendations were given. My daughter has not been the same since her shots. She still complains of feeling 85% with muscle aches and twitching.
This spontaneous report was received from a nurse referring to unspecified patients of unknown age and gender. The patients' medical histories and concurrent conditions were not reported. On unspecified dates since 24-OCT-2015, the patients were vaccinated with doses of GARDASIL (Lot# L033347; expiration date 23-JUL-2017) (dose and route of administration were not reported), which were exposed to temperatures outside of the recommended range. Concomitant therapies were not reported. No adverse experiences have been reported. There was no product quality complaint (PQC) involved. This is one of several reports from the same source. Additional information has been requested.
Pain in left arm  (about three inches below shoulder) when abducting, especially severe when moving arm (abducting) rapidly. Pain level is a 10 when arm is moved rapidly. Pain level is manageable (3-4) when moved more slowly. Tingling in fingers (left hand) for 1-2 hours after severe pain is triggered.
Herpes zoster; Subsequent to the ZOSTAVAX inoculation, the pt was treated by a physician at a healthcare center; This initial spontaneous report was received from a lawyer regarding a case in litigation involving a male patient (pt) of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date in 2015, the pt was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dosage regimen, route of administration, lot number and expiration date were not reported) at a pharmacy as prescribed and/or administered by a healthcare provider, for the long-term prevention of shingles and herpes Zoster related conditions.  Subsequent to the zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by a physician at a healthcare center (vaccination failure). It was reported that the pt would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the herpes zoster and vaccination failure was not reported.   The reporter considered the herpes zoster and vaccination failure to be related to Zoster Vaccine Live (ZOSTAVAX).
Unable to perform his routine work, cannot put clothes on his body; Allergy all over the body; Rash; Small pimples in red color; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Small pimples in red color), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to perform his routine work, cannot put clothes on his body), HYPERSENSITIVITY (Allergy all over the body) and RASH (Rash) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SIMVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], METFORMIN, INSULIN LISPRO (HUMALOG), INSULIN GLARGINE (BASAGLAR) and LISINOPRIL for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced ACNE (Small pimples in red color), HYPERSENSITIVITY (Allergy all over the body) and RASH (Rash). On 19-Apr-2021, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to perform his routine work, cannot put clothes on his body). The patient was treated with LORATADINE for Adverse event, at an unspecified dose and frequency. At the time of the report, ACNE (Small pimples in red color), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to perform his routine work, cannot put clothes on his body), HYPERSENSITIVITY (Allergy all over the body) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient stated that he stopped taking all the medicines.
Began feeling very achy, nausea with dry heves, dizziness, took 4 hours till patient began to feel better.
A report has been received from a Health Professional concerning a 47 year old, male subject who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 27-Jan-2014. The patent experienced ADMINISTRATION OF EXPIRED DOSE which started on 27-Jan-2014. The outcome of the event of ADMINISTRATION OF EXPIRED DOSE is unknown. The report was considered to be non-serious by the reporter.
Patient was 17 years old at time of administration of Moderna Covid-19 Vaccine which is approved for use for patients 18 and older.
Sore arm; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007MZ0A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, VITAMIN C [ASCORBIC ACID] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications provided.   This case was linked to MOD-2021-375409, MOD-2021-375383 (Patient Link).
Foot Became Swollen; Feet are Swollen; Can't Walk/Almost Cannot Walk; pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 70 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization.The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "Foot Became Swollen; Feet are Swollen"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "Can't Walk/Almost Cannot Walk"; PAIN (non-serious), outcome "unknown", described as "pain". The events "foot became swollen; feet are swollen", "can't walk/almost cannot walk" and "pain" were evaluated at the physician office visit.  Additional information: Caller reports that she received both Pfizer Covid vaccine doses and after her second vaccine dose her foot became swollen and she almost can't walk. Caller reports that they went to 2 different doctors who can't figure out what is wrong and advised them to call Pfizer. Caller reports "My sister is in trouble, she's crying she was vaccinated twice by Pfizer and her foot became swollen almost instantly, 2 days after her shot. Now she cannot walk, she is in pain, the doctors don't understand and can't find anything wrong". Caller now asking, what can she do to make it better, caller asking for medical advice.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
12 hours s/p vaccine  The patient developed fever to 102.5  taken orally.  She had body aches, Headache, nausea and vomiting.  By the second day the patient developed mild facial swelling  bilaterally, this responded well to Zyrtec.  There was no SOB, or dyspnea.  There was no swelling of lips or oropharyngeal structures.  Her symptoms  persisted for 48 hours.  Patient was treated at home by her mother, who is a pharmacist, with apap alternating with ibuprofen.  She was also given Zyrtec as noted.  The patient was seen by me this afternoon and was improved with no fever evident.  However, Mom had given her 1 gram apap 1 hour prior to her visit.
Myalgias, fever, injection site pain, rigors (8h - 36h) Fatigue and brain fog (24h-96h) Tender axillary adenopathy on injection side (started day 4, resolved by day 8) Tender bruising on both palms (started day 6)
Flu like symptoms.  Sore shoulders joints, hip joints, knee joints.  Muscle aches in upper torso and thighs.  Scratchy throat (started on day 2), tired, I just want to sleep.  Mild congestion at night.  No determinable elevation in temperature. Soreness at injection site.   Symptoms are still present 44 hours after injection.